The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms

Stem Cell Research and Therapy

Volumn 3, Issue 1, 2012, Pages

  Morando, Sara ^a,b   Vigo, Tiziana ^a,b   Esposito, Marianna ^c   Casazza, Simona ^a,b   Novi, Giovanni ^a   Principato, Maria ^a,b   Furlan, Roberto ^c   Uccelli, Antonio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DEMYELINATING DISEASE; DEMYELINATION; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MESODERM; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; THERAPY EFFECT; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT RESPONSE; ANIMAL; CD4+ T LYMPHOCYTE; CYTOLOGY; DRUG ADMINISTRATION ROUTE; IMMUNOLOGY; MESENCHYMAL STEM CELL; METABOLISM;

ANIMALIA;

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; DRUG ADMINISTRATION ROUTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS;

EID: 84856305316     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt94     Document Type: Review

References (38)

1. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS, Nature 2010 466 829 834 10.1038/nature09262 20703299
2. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, Satoh E, Morikawa S, Okada Y, Mabuchi Y, Katoh H, Okada S, Fukuda K, Suda T, Matsuzaki Y, Toyama Y, Okano H, Cell Stem Cell 2008 2 392 403 10.1016/j.stem.2008.03.005 18397758 (Pubitemid 351455244)
3. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Phinney DG, Prockop DJ, Stem Cells 2007 25 2896 2902 10.1634/stemcells.2007-0637 17901396 (Pubitemid 350127874)
4. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM, Blood 2002 99 3838 3843 10.1182/blood.V99.10.3838 11986244 (Pubitemid 34534559)
5. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R, Exp Hematol 2002 30 42 48 10.1016/S0301-472X(01)00769-X 11823036 (Pubitemid 34059216)
6. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A, Blood 2005 106 1755 1761 10.1182/blood-2005-04-1496 15905186 (Pubitemid 41208591)
7. Experimental autoimmune encephalomyelitis in the mouse. Miller SD, Karpus WJ, Davidson TS, Current Protoc Immunol 2010 chapter 15 unit 15.1 20143314
8. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Steinman L, Nat Med 2007 13 139 145 10.1038/nm1551 17290272
9. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Gold R, Linington C, Lassmann H, Brain 2006 129 1953 1971 10.1093/brain/awl075 16632554 (Pubitemid 44289062)
10. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, Mitchell JB, Hammill L, Vanguri P, Chopp M, Exp Neurol 2005 195 16 26 10.1016/j.expneurol.2005.03.018 15904921 (Pubitemid 41116810)
11. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantegazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A, Ann Neurol 2007 61 219 227 10.1002/ana.21076 17387730 (Pubitemid 46557346)
12. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D, Arch Neurol 2008 65 753 761 10.1001/archneur.65.6.753 18541795 (Pubitemid 351831453)
13. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Gordon D, Pavlovska G, Glover CP, Uney JB, Wraith D, Scolding NJ, Neurosci Lett 2008 448 71 73 10.1016/j.neulet.2008.10.040 18950680
14. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J, J Immunol 2009 182 5994 6002 10.4049/jimmunol.0803962 19414750
15. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, Gini B, Bach SD, Martinello M, Bifari F, Galiè M, Turano E, Budui S, Sbarbati A, Krampera M, Bonetti B, Stem Cells 2009 27 2624 2635 10.1002/stem.194 19676124
16. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH, Glia 2009 57 1192 1203 10.1002/glia.20841 19191336
17. Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Lanz TV, Opitz CA, Ho PP, Agrawal A, Lutz C, Weller M, Mellor AL, Steinman L, Wick W, Platten M, Stem Cells Dev 2010 19 657 668 10.1089/scd.2009.0385 19886804
18. 2. Matysiak M, Orlowski W, Fortak-Michalska M, Jurewicz A, Selmaj K, J Neuroimmunol 2011 233 106 111 10.1016/j.jneuroim.2010.12.004 21354631
19. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. Barhum Y, Gai-Castro S, Bahat-Stromza M, Barzilay R, Melamed E, Offen D, J Mol Neurosci 2010 41 129 137 10.1007/s12031-009-9302-8 19902385
20. Mesenchymal stem cells in health and disease. Uccelli A, Moretta L, Pistoia V, Nat Rev Immunol 2008 8 726 736 10.1038/nri2395 19172693
21. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. Zhang J, Li Y, Lu M, Cui Y, Chen J, Noffsinger L, Elias SB, Chopp M, J Neurosci Res 2006 84 587 595 10.1002/jnr.20962 16773650 (Pubitemid 44196699)
22. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Rivera FJ, Couillard-Despres S, Pedre X, Ploetz S, Caioni M, Lois C, Bogdahn U, Aigner L, Stem Cells 2006 24 2209 2219 10.1634/stemcells. 2005-0614 16763198 (Pubitemid 44527474)
23. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. Lanza C, Morando S, Voci A, Canesi L, Principato MC, Serpero LD, Mancardi G, Uccelli A, Vergani L, J Neurochem 2009 110 1674 1684 10.1111/j.1471-4159.2009.06268.x 19619133
24. Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease. Ripoll CB, Flaat M, Klopf-Eiermann J, Fisher-Perkins JM, Trygg CB, Scruggs BA, McCants ML, Leonard HP, Lin AF, Zhang S, Eagle ME, Alvarez X, Li YT, Li SC, Gimble JM, Bunnell BA, Stem Cells 2011 29 67 77 10.1002/stem.555 21280158
25. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK, PloS One 2011 6 19808 10.1371/journal.pone.0019808 21625635
26. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. Kemp K, Hares K, Mallam E, Heesom KJ, Scolding N, Wilkins A, J Neurochem 2010 114 1569 1580 10.1111/j.1471-4159.2009.06553.x 20028455
27. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ, Proc Natl Acad Sci USA 2008 105 14638 14643 10.1073/pnas.0803670105 18794523
28. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M, Neurology 2002 59 514 523 12196642 (Pubitemid 34919983)
29. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Akiyama Y, Radtke C, Honmou O, Kocsis JD, Glia 2002 39 229 236 10.1002/glia.10102 12203389
30. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ, Cell Stem Cell 2009 5 54 63 10.1016/j.stem.2009.05. 003 19570514
31. Mesenchymal stem cell homing: the devil is in the details. Karp JM, Leng Teo GS, Cell Stem Cell 2009 4 206 216 10.1016/j.stem.2009.02.001 19265660
32. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ, Proc Natl Acad Sci USA 2005 102 18171 18176 10.1073/pnas.0508945102 16330757 (Pubitemid 41798520)
33. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Uccelli A, Prockop DJ, Current Opin Immunol 2010 22 768 774 10.1016/j.coi.2010. 10.012 21093239
34. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G, Arthritis Rheum 2007 56 1175 1186 10.1002/art.22511 17393437 (Pubitemid 46608642)
35. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. Ghannam S, Pene J, Torcy-Moquet G, Jorgensen C, Yssel H, J Immunol 2010 185 302 312 10.4049/jimmunol.0902007 20511548
36. Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: implication for multiple sclerosis. Darlington PJ, Boivin MN, Renoux C, Francois M, Galipeau J, Freedman MS, Atkins HL, Cohen JA, Solchaga L, Bar-Or A, Ann Neurol 2010 68 540 545 10.1002/ana.22065 20661924
37. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, Le Blanc K, Uccelli A, Mult Scler 2010 16 503 510 10.1177/1352458509359727 20086020
38. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Uccelli A, Laroni A, Freedman MS, Lancet Neurol 2011 10 649 656 10.1016/S1474-4422(11)70121-1 21683930